Transcutaneous immunization with imiquimod is amplified by CD40 ligation and results in sustained cytotoxic T-lymphocyte activation and tumor protection

Author： Warger Tobias  

Publisher： Humana Press, Inc

ISSN： 1080-0549

Source： Clinical Reviews in Allergy and Immunology, Vol.32, Iss.1, 2007-02, pp. : 57-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prime–boost immunization generates a high frequency, high-avidity CD8 + cytotoxic T lymphocyte population

By Estcourt M.J.  

International Immunology, Vol. 14, Iss. 1, 2002-01 ,pp. : 31-37

Oxford University Press

Access to resources Recommend Favorite

Cytotoxic T-lymphocyte antigen-4 and programmed death-1 function as negative regulators of lymphocyte activation

By Carter Laura   Carreno Beatriz  

Immunologic Research, Vol. 28, Iss. 1, 2003-08 ,pp. : 49-59

Humana Press, Inc

Access to resources Recommend Favorite

Dependence of T-lymphocyte activation on the extent of cellular damage

By Arneth Borros M.  

International Journal of Immunological Studies, Vol. 1, Iss. 2, 2010-08 ,pp. : 183-194

Inderscience Publishers

Access to resources Recommend Favorite

Effect of Aerva lanata on cell-mediated immune responses and cytotoxic T-lymphocyte generation in normal and tumor-bearing mice

By Siveen K. S.   Kuttan Girija  

Journal of Immunotoxicology, Vol. 9, Iss. 1, 2012-03 ,pp. : 25-33

Informa Healthcare

Access to resources Recommend Favorite

B7.2-Ig fusion proteins enhance IL-4-dependent differentiation of tumor-sensitized CD8 + cytotoxic T lymphocyte precursors

By Hiraoka Shin-ichiro  

International Immunology, Vol. 17, Iss. 8, 2005-08 ,pp. : 1071-1079

Oxford University Press

Access to resources Recommend Favorite